Medications for Uveitis

13 results
  • abrilada - adalimumab - afzb

    (Adalimumab-Afzb)
    Pfizer Laboratories Div Pfizer Inc
    Abrilada is a TNF blocker indicated for moderate-to-severe rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, juvenile idiopathic arthritis (age 2+), Crohn's disease (age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults.
  • amjevita - adalimumab - atto injection

    (Adalimumab-Atto)
    Amgen, Inc
    TNF blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults and eligible pediatric patients.
  • hadlima - adalimumab - bwwd solution

    (Adalimumab-Bwwd)
    Organon Llc
    HADLIMA is a TNF blocker for adults and children with moderately to severely active rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis. Also indicated for juvenile idiopathic arthritis in patients 2 years and older.
  • hulio - adalimumab - fkjp

    (Adalimumab-Fkjp)
    Biocon Biologics Inc
    Hulio (adalimumab) is a TNF blocker indicated for rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and non-infectious uveitis in adults; JIA and Crohn's disease also cover pediatric patients.
  • humira - adalimumab

    (Adalimumab)
    Abbvie Inc.
    HUMIRA is a TNF blocker indicated for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, juvenile idiopathic arthritis, and non-infectious uveitis in adults and eligible pediatric patients.
  • hyrimoz - adalimumab - adaz injection, solution

    (Adalimumab-Adaz)
    Sandoz Inc
    Hyrimoz is a TNF-blocker for rheumatoid arthritis, polyarticular juvenile idiopathic arthritis (age 2+), psoriatic arthritis, ankylosing spondylitis, Crohn's disease (adults/pediatric age 6+), ulcerative colitis, chronic plaque psoriasis, hidradenitis suppurativa (age 12+), and non-infectious uveitis (adults/pediatric age 2+).
  • iluvien - fluocinolone acetonide implant

    (Fluocinolone Acetonide)
    Alimera Sciences, Inc.
    ILUVIEN is a corticosteroid implant indicated for diabetic macular edema (DME) in patients previously treated with corticosteroids without significant intraocular pressure increase, and for chronic non-infectious uveitis affecting the posterior segment of the eye.
  • ozurdex - dexamethasone implant

    (Dexamethasone)
    Allergan, Inc.
    OZURDEX treats macular edema from branch or central retinal vein occlusion, non-infectious uveitis affecting the posterior eye segment, and diabetic macular edema.
  • purified cortrophin gel - repository corticotropin injection

    (Repository Corticotropin)
    Ani Pharmaceuticals, Inc.
    Purified Cortrophin Gel treats rheumatic disorders (psoriatic arthritis, rheumatoid arthritis, ankylosing spondylitis), collagen diseases (lupus, polymyositis), severe skin conditions, allergic states, inflammatory eye diseases, sarcoidosis, nephrotic syndrome, and acute multiple sclerosis exacerbations.
  • rayos

    (Prednisone)
    Horizon Therapeutics Usa, Inc.
    Rayos (prednisone) treats a wide range of inflammatory and autoimmune conditions including allergic reactions, skin diseases, rheumatologic disorders, respiratory conditions, hematologic diseases, organ transplant rejection, and certain cancers in adults and children.